.Zevra Rehabs' unusual condition drug seems to become on the course to authorization this loss after...
.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failing has gone a $230 million ...
.After more than 20 years of focus on neurodegenerative ailments, Swiss biotech AC Immune claims it ...
.GSK has ditched a period 2 individual papillomavirus (HPV) vaccine coming from its pipe after deter...
.Operating system Therapies will certainly specify on the NYSE American inventory exchange this morn...
.ALX Oncology's phase 2 stomach cancer feedback cost has actually diminished. After seeing its own C...
.Another of Ionis Pharmaceuticals' essential midphase readouts has fallen short of desires, motivati...
.While Biogen's pharma peers are looking for late-stage resources along with little bit of threat, C...
.Instil Biography has been actually a biotech looking for a pipeline after it ditched its own lead p...
.Biogen has actually handed back rights to an early Alzheimer's illness program to Denali Rehabs, go...